1. Home
  2. TVTX vs SID Comparison

TVTX vs SID Comparison

Compare TVTX & SID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • SID
  • Stock Information
  • Founded
  • TVTX 2008
  • SID 1941
  • Country
  • TVTX United States
  • SID Brazil
  • Employees
  • TVTX N/A
  • SID N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • SID Steel/Iron Ore
  • Sector
  • TVTX Health Care
  • SID Industrials
  • Exchange
  • TVTX Nasdaq
  • SID Nasdaq
  • Market Cap
  • TVTX 1.7B
  • SID 2.0B
  • IPO Year
  • TVTX N/A
  • SID 1997
  • Fundamental
  • Price
  • TVTX $20.44
  • SID $1.73
  • Analyst Decision
  • TVTX Strong Buy
  • SID Strong Sell
  • Analyst Count
  • TVTX 14
  • SID 1
  • Target Price
  • TVTX $33.31
  • SID $1.30
  • AVG Volume (30 Days)
  • TVTX 1.6M
  • SID 2.0M
  • Earning Date
  • TVTX 05-01-2025
  • SID 05-08-2025
  • Dividend Yield
  • TVTX N/A
  • SID 12.87%
  • EPS Growth
  • TVTX N/A
  • SID N/A
  • EPS
  • TVTX N/A
  • SID N/A
  • Revenue
  • TVTX $273,533,000.00
  • SID $7,063,567,739.00
  • Revenue This Year
  • TVTX $68.31
  • SID $7.06
  • Revenue Next Year
  • TVTX $55.65
  • SID $3.65
  • P/E Ratio
  • TVTX N/A
  • SID N/A
  • Revenue Growth
  • TVTX 75.65
  • SID N/A
  • 52 Week Low
  • TVTX $6.01
  • SID $1.27
  • 52 Week High
  • TVTX $25.29
  • SID $2.85
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 61.49
  • SID 60.45
  • Support Level
  • TVTX $19.84
  • SID $1.63
  • Resistance Level
  • TVTX $22.07
  • SID $1.72
  • Average True Range (ATR)
  • TVTX 1.11
  • SID 0.06
  • MACD
  • TVTX 0.42
  • SID 0.01
  • Stochastic Oscillator
  • TVTX 77.85
  • SID 94.23

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About SID Companhia Siderurgica Nacional S.A.

Companhia Siderurgica Nacional is an integrated steel producer. The company operate throughout the entire steel production chain, from the mining of iron ore to the production and sale of a diversified range of steel products. It operates in five segments namely, Steel, Mining, Logistics, Energy, and Cement. It generates maximum revenue from the steel segment. Geographically, it derives a majority of revenue from Asia.

Share on Social Networks: